Jiage Ding相关文献与解析，生知库 | 链接生命科学的每一步

Yanyan Zheng #,Jiawei Wang #,Guangya Zhao,Zichun Zhang,Yingxiang Shao,Bowen Lu,Yuchen Zhang,Renjin Chen,Li Sun,Xiaohui Xie,Jiage Ding,Junnian Zheng,Dafei Chai

肾癌

肿瘤

免疫/内分泌

肿瘤免疫

发表日期：2025

文献求助收藏

Adenovirus vaccine targeting kinases induces potent antitumor immunity in solid tumors

靶向激酶的腺病毒疫苗可诱导实体瘤产生强效的抗肿瘤免疫反应

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.3

doi:10.1136/jitc-2024-009869

Fei Zhu # ，Zheng Lu # ，Wenjing Tang ，Guangya Zhao ，Yingxiang Shao ，Bowen Lu ，Jiage Ding ，Yanyan Zheng ，Lin Fang ，Huizhong Li ，Gang Wang ，Renjin Chen ，Junnian Zheng ，Dafei Chai

The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma

腺病毒介导的免疫检查点疫苗联合递送可对肾癌产生强效的抗肿瘤作用。

期刊:NPJ Vaccines

影响因子:6.9

doi:10.1038/s41541-023-00706-x

Nan Jiang # ，Yanyan Zheng # ，Jiage Ding ，Jiawei Wang ，Fei Zhu ，Meng Wang ，Navid Sobhani ，Praveen Neeli ，Gang Wang ，Hailong Li ，Junnian Zheng ，Dafei Chai

Adenovirus-assembled DC vaccine induces dual-targeting CTLs for tumor antigen and adenovirus to eradicate tumors

腺病毒组装DC疫苗诱导针对肿瘤抗原和腺病毒的双靶向CTL消灭肿瘤

期刊:International Immunopharmacology

影响因子:4.8

doi:10.1016/j.intimp.2023.110722

Jiage Ding, Yanyan Zheng, Fei Zhu, Meng Wang, Lin Fang, Huizhong Li, Hui Tian, Yong Liu, Gang Wang, Junnian Zheng, Dafei Chai

HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8+T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma

HMGB1/GPC3双靶向疫苗可诱导树突状细胞介导的CD8+T细胞免疫应答，并在肝细胞癌中发挥潜在的治疗作用。

期刊:iScience

影响因子:4.6

doi:10.1016/j.isci.2023.106143

Xiaoqing Shi ，Jiage Ding ，Yanyan Zheng ，Jiawei Wang ，Navid Sobhani ，Praveen Neeli ，Gang Wang ，Junnian Zheng ，Dafei Chai

Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8+ T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma

治疗性腺病毒疫苗与 IL-12 联合免疫在肝细胞癌中诱导强效 CD8+ T 细胞抗肿瘤免疫

期刊:Cancers

影响因子:

doi:10.3390/cancers14184512

Yanyan Zheng, Zheng Lu, Jiage Ding, Nan Jiang, Jiawei Wang, Jie Yang, Jingyuan Song, Hongliang Chen, Lin Fang, Huizhong Li, Hui Tian, Gang Wang, Junnian Zheng, Dafei Chai

Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity

FGL1/CAIX 双靶向疫苗通过激活 DC 介导的多功能 CD8 T 细胞免疫表现出强大的抗肿瘤活性

期刊:Molecular Therapy-Oncolytics

影响因子:5.3

doi:10.1016/j.omto.2021.11.017

Dafei Chai, Dong Qiu, Xiaoqing Shi, Jiage Ding, Nan Jiang, Zichun Zhang, Jiawei Wang, Jie Yang, Pengli Xiao, Gang Wang, Junnian Zheng

Co-immunization with L-Myc enhances CD8+ or CD103+ DCs mediated tumor-specific multi-functional CD8+ T cell responses

与 L-Myc 联合免疫可增强 CD8+ 或 CD103+ DCs 介导的肿瘤特异性多功能 CD8+ T 细胞反应

期刊:Cancer Science

影响因子:4.5

doi:10.1111/cas.15044

Dafei Chai, Zichun Zhang, Nan Jiang, Jiage Ding, Dong Qiu, Shang Yuchen Shi, Gang Wang, Lin Fang, Huizhong Li, Hui Tian, Jie Yang, Qing Zhang, Junnian Zheng

CAIX-specific CAR-T Cells and Sunitinib Show Synergistic Effects Against Metastatic Renal Cancer Models

CAIX 特异性 CAR-T 细胞和舒尼替尼对转移性肾癌模型表现出协同作用

期刊:Journal of Immunotherapy

影响因子:3.2

doi:10.1097/CJI.0000000000000301

Huizhong Li, Jiage Ding, Mengmeng Lu, Hongyan Liu, Yangna Miao, Liantao Li, Gang Wang, Junnian Zheng, Dongsheng Pei, Qing Zhang

Bortezomib improves adoptive carbonic anhydrase IX‑specific chimeric antigen receptor‑modified NK92 cell therapy in mouse models of human renal cell carcinoma

硼替佐米可改善人类肾细胞癌小鼠模型中碳酸酐酶 IX 特异性嵌合抗原受体修饰的 NK92 细胞治疗

期刊:Oncology Reports

影响因子:3.8

doi:10.3892/or.2018.6731

Qing Zhang, Jinjing Xu, Jiage Ding, Hongyan Liu, Huizhong Li, Hailong Li, Mengmeng Lu, Yangna Miao, Zhenzhen Wang, Qiang Fu, Junnian Zheng

Targeting Siglec-E facilitates tumor vaccine-induced antitumor immunity in renal carcinoma

靶向Siglec-E可促进肾癌中肿瘤疫苗诱导的抗肿瘤免疫

Adenovirus vaccine targeting kinases induces potent antitumor immunity in solid tumors

靶向激酶的腺病毒疫苗可诱导实体瘤产生强效的抗肿瘤免疫反应

The co-delivery of adenovirus-based immune checkpoint vaccine elicits a potent anti-tumor effect in renal carcinoma

腺病毒介导的免疫检查点疫苗联合递送可对肾癌产生强效的抗肿瘤作用。

Adenovirus-assembled DC vaccine induces dual-targeting CTLs for tumor antigen and adenovirus to eradicate tumors

腺病毒组装DC疫苗诱导针对肿瘤抗原和腺病毒的双靶向CTL消灭肿瘤

HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8+T cell immune response and elicits potential therapeutic effect in hepatocellular carcinoma

HMGB1/GPC3双靶向疫苗可诱导树突状细胞介导的CD8+T细胞免疫应答，并在肝细胞癌中发挥潜在的治疗作用。

Therapeutic Adenovirus Vaccine Combined Immunization with IL-12 Induces Potent CD8+ T Cell Anti-Tumor Immunity in Hepatocellular Carcinoma

治疗性腺病毒疫苗与 IL-12 联合免疫在肝细胞癌中诱导强效 CD8+ T 细胞抗肿瘤免疫

Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity

FGL1/CAIX 双靶向疫苗通过激活 DC 介导的多功能 CD8 T 细胞免疫表现出强大的抗肿瘤活性

Co-immunization with L-Myc enhances CD8+ or CD103+ DCs mediated tumor-specific multi-functional CD8+ T cell responses

与 L-Myc 联合免疫可增强 CD8+ 或 CD103+ DCs 介导的肿瘤特异性多功能 CD8+ T 细胞反应

CAIX-specific CAR-T Cells and Sunitinib Show Synergistic Effects Against Metastatic Renal Cancer Models

CAIX 特异性 CAR-T 细胞和舒尼替尼对转移性肾癌模型表现出协同作用

Bortezomib improves adoptive carbonic anhydrase IX‑specific chimeric antigen receptor‑modified NK92 cell therapy in mouse models of human renal cell carcinoma

硼替佐米可改善人类肾细胞癌小鼠模型中碳酸酐酶 IX 特异性嵌合抗原受体修饰的 NK92 细胞治疗